Moderna

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Moderna 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. 

CEO
Stéphane Bancel
CEOStéphane Bancel
Employees
5,800
Employees5,800
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2010
Founded2010
Employees
5,800
Employees5,800

MRNA Key Statistics

Market cap
10.61B
Market cap10.61B
Price-Earnings ratio
-3.61
Price-Earnings ratio-3.61
Dividend yield
Dividend yield
Average volume
12.94M
Average volume12.94M
High today
$28.25
High today$28.25
Low today
$26.87
Low today$26.87
Open price
$27.81
Open price$27.81
Volume
15.70M
Volume15.70M
52 Week high
$56.70
52 Week high$56.70
52 Week low
$23.15
52 Week low$23.15

MRNA News

Benzinga 2d
Moderna Stock Is Trading Lower Friday: What's Going On?

Moderna Inc (NASDAQ:MRNA) shares are trading lower on Friday afternoon, giving back a portion of the gains seen on Thursday. Here’s what investors need to know....

Moderna Stock Is Trading Lower Friday: What's Going On?
Investopedia 3d
S&P 500 Gains and Losses Today: Meta Stock Drops After Earnings; Moderna Surges

Close Key Takeaways A social media giant faltered on Thursday, Oct. 30, 2025, as artificial intelligence costs piled up, while a biotech name benefited from re...

S&P 500 Gains and Losses Today: Meta Stock Drops After Earnings; Moderna Surges
TipRanks 3d
Moderna Stock Surges 17% on Buyout Speculation ahead of Q3 Earnings

Moderna (MRNA) stock jumped 17% on Thursday, fueled by speculation of potential buyout talks amid concerns over declining COVID-related revenues and rising R&D...

Analyst ratings

59%

of 27 ratings
Buy
22.2%
Hold
59.3%
Sell
18.5%

More MRNA News

Sherwood News 3d
Moderna soars after STAT reports “a buyout or a large partnership” are on the table

J. Edward Moreno 19m Moderna soars after STAT reports “a buyout or a large partnership” are on the table Moderna rose nearly 15% on Thursday after STAT reported...

Moderna soars after STAT reports “a buyout or a large partnership” are on the table
TipRanks 3d
Moderna up 8% after STAT report on buyout potential

Shares of Moderna (MRNA) are up $1.97, or 8% to $26.67 in morning trading. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unl...

TipRanks 6d
Vertex and Moderna’s VX-522 Study: A Potential Breakthrough in Cystic Fibrosis Treatment

Vertex Pharmaceuticals Inc. ((VRTX)), Moderna ((MRNA)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of...

People also own

Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.